Govt approves Bharat Biotech's Ankleshwar plant to produce Covaxin: Mandaviya"Govt of India approves vaccine manufacturing facility for production of @BharatBiotech's #Covaxin in Ankleshwar, Gujarat," Mandaviya tweet...
10 Aug, 2021, 02.17 PM IST
Bharat Biotech raises Covaxin capacity by another 200 million doses a year“The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...
21 May, 2021, 07.09 AM IST
Bharat Biotech to ramp up Covaxin production by additional 200 million doses"The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...
20 May, 2021, 10.59 PM IST
How Krishna Ella built Bharat Biotech and why the company is at a tipping pointBharat Biotech’s Covaxin is India’s first indigenous coronavirus vaccine. The DCGI’s approval of Covaxin, despite it not having phase-3 cli...
09 Jan, 2021, 11.00 PM IST
Bharat Biotech's subsidiary Chiron Behring launches anti-rabies vaccine“In our ongoing commitment to address the supply shortages of rabies vaccine, we are making additional investments to increase production c...
13 Nov, 2019, 10.02 PM IST
Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...
23 Dec, 2014, 08.48 PM IST
Novartis India strikes 8.7 lakh square feet office space deal in HyderabadPharmaceutical firm Novartis has picked up 8.7 lakh square feet of office space in Hyderabad in a bid to consolidate its operations in the ...
03 Jan, 2014, 03.04 AM IST
Drugs pricing row: 7 pharmaceutical companies move HC against Centre's orderSeven more pharmaceutical companies including Novartis India Limited today moved the Delhi High Court to challenge the government's new dru...
05 Aug, 2013, 06.45 PM IST
- Aventis Pharma Q4 net zooms four-fold to Rs 104.9 cr
Aventis Pharma on Wednesday said its net profit surged over four-fold to Rs 104.9 crore in the fourth quarter ended December 31, 2010, over...
16 Feb, 2011, 07.20 PM IST
- Aventis completes CBVPL stake sale; pockets Rs 100 cr
The company, which completed stake sale on December 23, received sale consideration of Rs 1,007.5mn (USD 22.399mn), Aventis Pharma said in ...
27 Dec, 2010, 06.46 PM IST
- Novartis to buy Aventis stake in rabies vaccine JV for $22 million
Aventis Pharma, the Indian arm of Sanofi Aventis, is exiting its joint venture Chiron Behring Vaccines by selling its 49% to the other part...
14 Dec, 2010, 01.48 AM IST
- Aventis to exit JV with Novartis, sell stake for about Rs 100cr
Aventis has agreed to continue to provide certain utilities in services to the Ankleshwar plant of CBVPL for a period of 3 yrs from the dat...
13 Dec, 2010, 02.18 PM IST
- HC stays Aventis' anti-rabies drug distribution
The Bombay High Court has restrained Aventis Pharma from distributing anti-rabies vaccine Verorab, and allowed the arbitration application ...
23 Dec, 2009, 04.11 AM IST
- No shortage of rabies vaccine: Novartis India
Novartis India said there was no shortage of rabies vaccine in the country, despite manufacturing constraints at Ankaleswar plant of Chiron...
28 Oct, 2009, 12.21 AM IST
- Novartis-Aventis row leads to shortage of anti-rabies vaccine
Beware of Dogs! There is a shortage of anti-rabies vaccine in the country, thanks to a dispute between Novartis and Sanofi Aventis, which t...
26 Oct, 2009, 12.29 AM IST
- SC notice to Aventis Pharma on Novartis plea
The Supreme Court today issued notice to Aventis Pharma Ltd on a petition filed by Novartis Vaccines & Diagnostics Inc seeking reference of...
10 Dec, 2007, 09.38 PM IST